A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)
Clinical trial NCT02795325 · TERMINATED
Trial details
- NCT number
- NCT02795325
- Sponsor
- Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-13
- Primary completion
- 2016-10-14
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.